Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Downgrades C3.ai to Hold

Needham analyst Mike Cikos downgrades C3.ai (NYSE:AI) from Buy to Hold.

byBenzinga Newsdesk

September 2, 2022

1 minute read

Needham analyst Mike Cikos downgrades C3.ai (NYSE:AI) from Buy to Hold.

Mid-Day Market Update: Crude Oil Rises 2%; UpHealth Shares Plunge

By Lisa Levin

Today, 10:41 PM

Midway through trading Tuesday, the Dow traded up 1.25% to 34,429.02 while the NASDAQ rose 1.42% to 14,458.35. The S&P also rose, gaining 1.33% to 4,357.69.

AGFY

HC Wainwright & Co. Maintains Buy on Protagonist Therapeutics, Raises Price Target to $60

By Benzinga Newsdesk

Today, 10:41 PM

HC Wainwright & Co. analyst Douglas Tsao maintains Protagonist Therapeutics (NASDAQ:PTGX) with a Buy and raises the price target from $50 to $60.

PTGX

Credit Suisse Initiates Coverage On VMware with Outperform Rating, Announces Price Target of $175

By Benzinga Newsdesk

Today, 10:41 PM

Credit Suisse analyst Phil Winslow initiates coverage on VMware (NYSE:VMW) with a Outperform rating and announces Price Target of $175.

VMW

Keybanc Maintains Overweight on Twilio, Raises Price Target to $445

By Benzinga Newsdesk

Today, 10:41 PM

Keybanc maintains Twilio (NYSE:TWLO) with a Overweight and raises the price target from $424 to $445.

TWLO

Needham Downgrades C3.ai to Hold

Related Posts

Mid-Day Market Update: Crude Oil Rises 2%; UpHealth Shares Plunge

HC Wainwright & Co. Maintains Buy on Protagonist Therapeutics, Raises Price Target to $60

Credit Suisse Initiates Coverage On VMware with Outperform Rating, Announces Price Target of $175

Keybanc Maintains Overweight on Twilio, Raises Price Target to $445